Skip to main content
B

BIOSOLVIX 바이오솔빅스

This startup provides organoid-based drug efficacy and toxicity testing services, offering a cost-effective alternative to animal testing for pharmaceutical companies. Their human-like organoids enable accurate preclinical evaluation of new drug candidates.

Seoul, South KoreaFounded 2023410+ followers
Updated 18 months ago

Funding

Funding not disclosed

DC
Funding rounds are not available yet.

Founders

Product

Features

  • This startup provides organoid-based drug efficacy and toxicity testing services, offering a cost-effective alternative to animal testing for pharmaceutical companies. Their human-like organoids enable accurate preclinical evaluation of new drug candidates.
This profile is AI-generated and may contain inaccuracies.